Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia

Aliment Pharmacol Ther. 2024 Dec 30. doi: 10.1111/apt.18453. Online ahead of print.
No abstract available

Publication types

  • Editorial